MedPath

TOKA: Custom Made Devices for High Tibial Osteotomy (HTO) - Clinical Investigation

Not Applicable
Conditions
Unicompartmental Medial Knee Osteoarthritis
Interventions
Device: High Tibial Osteotomy
Registration Number
NCT04574570
Lead Sponsor
3D Metal Printing Ltd
Brief Summary

This preliminary pilot study is a single-centre, prospective, uncontrolled, 32-month study to assess the performance of personalised opening wedge High Tibial Osteotomy (HTO) treatment using the TOKA® device and procedure.

The medical device being examined is a custom-made device and therefore does not require a CE mark. Furthermore, the study will serve as a useful method of gathering clinical data and measuring device performance, as well as establishing a potential commercial relationship with the hospital administration.

Study Objectives::

1. to assess the morphology of the knee joint and the improvement of OA following the TOKA® treatment.

2. to Assess the functional outcome of the knee joint and the improvement of OA following the TOKA® treatment.

Outcomes Evaluations::

1. The morphology of the knee joint is assessed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the correction angle, hip-knee-ankle angle (HKA - mechanical axis), Mikulicz point (recorded as a percentage of the tibial width from the medial to the lateral region) and posterior slope, using the imaging techniques.

2. The functional outcome of the knee joint is assessed by a) performing a gait analysis of the patients pre-operatively and post-operatively, b) the use of clinical scoring...

.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Patients undergoing opening wedge Hight Tibial Osteotomy (HTO)
  • Patients must have completed a consent form for the study
  • Patients must be prepared to comply with the pre and post-operative investigations, rehabilitation, attendance schedule and questionnaire schedule of the study
  • Patient in whom any varus deformity present is <20°
  • The diagnosis is of unicompartmental medial osteoarthritis of the knee
  • Patient has primary diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD)
  • BMI<40
  • Age range 40 to 65 years
Exclusion Criteria
  • Refusal to consent to the study
  • Pregnancy
  • Prisoners
  • A patient known to have substance abuse or psychological disorders that could interfere with their ability to comply with the post-operative rehabilitation and assessment schedules
  • Patients unable to read or understand the patient information leaflet and consent form
  • Patient has a known sensitivity to device materials.
  • Patient has a Body Mass Index (BMI) ≥ 40.
  • Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation.
  • Patient has received any orthopaedic surgical intervention to the lower extremities within the past year or is expected to require any orthopaedic surgical intervention to the lower extremities, other than the HTO to be enrolled in this study, within the next year.
  • Patient requires bilateral HTO or has a history of unsuccessful contralateral partial replacement or HTO.
  • Patient has chronic heart failure (NYHA Stage ≥ 2)
  • Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device.
  • Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration.
  • Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. > 30 days).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
interventional patientHigh Tibial OsteotomyPersonalised High Tibial Osteotomy (HTO) using a patient-specific fixation plate (TOKA®)
Primary Outcome Measures
NameTimeMethod
Morphology Assessment via Mikulicz point assessmentAt 6 months after surgery

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the Mikulicz point reported in % of the tibial width from the medial to the lateral region, using image-based techniques.

Morphology Assessment via hip-knee-ankle angle assessmentAt 6 months after surgery

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the hip-knee-ankle angle (HKA - mechanical axis) reported in degree, using image-based techniques.

Morphology Assessment via correction angle assessmentAt 6 months after surgery

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the correction angle, using image-based techniques.

Morphology Assessment via posterior slope assessmentAt 6 months after surgery

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the posterior slope reported in degree, using image-based techniques.

Secondary Outcome Measures
NameTimeMethod
Functional Assessment via clinical scoring - Tegner scoreBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.

The functional assessment is performed via clinical scoring using the Tegner score. Tegner scale value range: \[min / max\]= 0 - 10, higher values mean better outcome.

Functional Assessment via clinical scoring - European Quality of life via 5-Dimensions questionnaireBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.

The functional assessment is performed via clinical scoring using the European Quality of life via 5-Dimensions questionnaire (EQ-5D). In applied EQ-5D, the respondents classify their own health status into 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression with 3 levels of severity (no problems, moderate problems, or severe problems. Based on that, patients could be classified into 243 health states and 2 additional states (unconscious and dead). The EQ-5D health states are converted into a single summary score by applying weights to each of the levels in each dimension, as is typically done in cost utility analysis. Health state index scores range from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.

Functional Assessment via clinical scoring - Knee Osteoarthritis Outcome ScoreBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.

The functional assessment is performed via clinical scoring using the Knee Osteoarthritis Outcome Score (KOOS). KOOS value range: \[min / max\]= 0 - 100, higher values mean better outcome.

Functional Assessment via clinical scoring - Knee Society System ScoreBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.

The functional assessment is performed via clinical scoring using the knee society system score (KSS). KSS value range: \[min / max\]= 0 - 100, higher values mean better outcome.

The functional assessment ivia x-ray examinationsBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.

The functional assessment is performed via x-ray examinations by reporting knee joint alligments in degrees..

Functional Assessment via gait analysis - kinematicsBefore surgery and at 6 months after surgery

The functional assessment is performed via three dimensional gait analysis of the patients before and after surgery. Relevant kinematic results are reported in terms of joint rotations (in degrees)..

Functional Assessment via gait analysis - kineticsBefore surgery and at 6 months after surgery

The functional assessment is performed via three dimensional gait analysis of the patients before and after surgery. Relevant kinematic results are reported in terms of joint moments (in N\*mm, normalized to patient's body weight times height).

Functional Assessment via clinical scoring - Visual Analogue ScaleBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.

The functional assessment is performed via clinical scoring using the Visual Analogue Scale (VAS). VAS is based on a 10-cm long straight line with one end meaning no pain and the other end meaning the worst pain; on this line, patients are asked to mark a point that matches the amount of pain they feel; the quantification of the point location with respect to the two ends is representative of the ammount of pain.

Trial Locations

Locations (1)

IRCCS Istituto Ortopedico Rizzoli

🇮🇹

Bologna, Italy

© Copyright 2025. All Rights Reserved by MedPath